UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001047
Receipt number R000001254
Scientific Title Cancer patient and family perception of the usefulness of a question prompt sheet during important consultation
Date of disclosure of the study information 2008/02/21
Last modified on 2009/02/23 12:27:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Cancer patient and family perception of the usefulness of a question prompt sheet during important consultation

Acronym

Cancer patient and family perception of the usefulness of a question prompt sheet during important consultation

Scientific Title

Cancer patient and family perception of the usefulness of a question prompt sheet during important consultation

Scientific Title:Acronym

Cancer patient and family perception of the usefulness of a question prompt sheet during important consultation

Region

Japan


Condition

Condition

lung, gastric, colorectal, esophageal cancer

Classification by specialty

Gastroenterology Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To determine the usefulness of a question prompt sheet for cancer patient and family communication with physicians

Basic objectives2

Others

Basic objectives -Others

the usefulness of a question prompt sheet

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The usefulness of a question prompt sheet/ hospital introduction sheet (3 items; 11 Likert scale)
" To understand the treatment plan, the sheet helped me to ask questions to the physician."
" To understand the treatment plan, the sheet was helpful."
" I will use the sheet again."

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Hospital introduction sheet
+ Question prompt sheet

Interventions/Control_2

Hospital introduction sheet

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients
1.Patients with advanced cancer (lung, gastric, colorectal, esophageal cancer ) attending their first important consultation with an oncologist after diagnosis
2.Patients who were informed of cancer diagnosis

Family
1. Patient's family

Key exclusion criteria

Patients
1.Patients with cognitive dysfunction
2.Patients with serious physical problems recognized by the primary physician or researchers
3.Patients with serious psychological distress recognized by the primary physician or researchers
4.Patients who are not able to communicate in Japanese

Family
Same as patients' exclusion criteria

Target sample size

260


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yosuke Uchitomi

Organization

Research Center for Innovative Oncology, National Cancer Center Hospital East

Division name

Psycho-Oncology Division

Zip code


Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan

TEL

04-7134-7013

Email



Public contact

Name of contact person

1st name
Middle name
Last name Yuki Shirai

Organization

Research Center for Innovative Oncology, National Cancer Center Hospital East

Division name

Psycho-Oncology Division

Zip code


Address

6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan

TEL

04-7134-7013

Homepage URL


Email



Sponsor or person

Institute

Research Center for Innovative Oncology, National Cancer Center Hospital East

Institute

Department

Personal name



Funding Source

Organization

Grant from Health and Labor Sciences Research Grants, the third-term comprehensive control research for cancer

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 02 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2007 Year 12 Month 19 Day

Date of IRB


Anticipated trial start date

2008 Year 02 Month 01 Day

Last follow-up date

2008 Year 12 Month 01 Day

Date of closure to data entry

2009 Year 01 Month 01 Day

Date trial data considered complete

2009 Year 02 Month 01 Day

Date analysis concluded

2009 Year 03 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 02 Month 21 Day

Last modified on

2009 Year 02 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001254


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name